Polyploidy mitigates the impact of DNA damage while simultaneously bearing its burden
Journal | Cell Death Discov. 10(1):436 (2024) |
---|---|
Title | Polyploidy mitigates the impact of DNA damage while simultaneously bearing its burden |
Laboratory | Laboratory of Ploidy Pathology〈Assoc. Prof. MATSUMOTO Tomonori〉 |
Abstract
Polyploidy is frequently enhanced under pathological conditions, such as tissue injury and cancer in humans. Polyploidization is critically involved in cancer evolution, including cancer initiation and the acquisition of drug resistance. However, the effect of polyploidy on cell fate remains unclear. In this study, we explored the effects of polyploidization on cellular responses to DNA damage and cell cycle progression. Through various comparisons based on ploidy stratifications of cultured cells, we found that polyploidization and the accumulation of genomic DNA damage mutually induce each other, resulting in polyploid cells consistently containing more genomic DNA damage than diploid cells under both physiological and stress conditions. Notably, despite substantial DNA damage, polyploid cells demonstrated a higher tolerance to its impact, exhibiting delayed cell cycle arrest and reduced secretion of inflammatory cytokines associated with DNA damage-induced senescence. Consistently, in mice with ploidy tracing, hepatocytes with high ploidy appeared to potentially persist in the damaged liver, while being susceptible to DNA damage. Polyploidy acts as a reservoir of genomic damage by mitigating the impact of DNA damage, while simultaneously enhancing its accumulation.

Fig. 1
Overview of this study
(A) We created special cells with double the usual number of chromosomes to investigate the relationship between polyploidy and DNA damage.
(B) After treatment with the anticancer drug cisplatin, we found that polyploid cells accumulated more DNA damage compared to normal cells. The bright spots in the image represent DNA damage captured under a microscope.
(C) Cisplatin is a drug that kills cancer cells by inducing extensive DNA damage. Despite the higher levels of DNA damage in polyploid cells, they showed greater resistance to cisplatin than diploid cells.
Authors | Kazuki Hayashi (1, 2, 3), Kisara Horisaka (1), Yoshiyuki Harada (1, 4), Yuta Ogawa (1, 3), Takako Yamashita (1, 3), Taku Kitano (1, 3, 5), Masahiro Wakita (1), Takahito Fukusumi (2), Hidenori Inohara (2), Eiji Hara (1, 6), Tomonori Matsumoto (1, 3)
|
---|---|
PubMed | 39397009 |